CRISPR-Cas13-Mediated Knockdown of lncRNA-GACAT3 Inhibited Cell Proliferation and Motility, and Induced Apoptosis by Increasing p21, Bax, and E-Cadherin Expression in Bladder Cancer

Clinical and Prognostic Implications of P21 (WAF1/CIP1) Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-Analysis

(2020) Junbo Wu et al.   DISEASE MARKERS

Reprogrammed CRISPR‑Cas13a targeting the HPV16/18 E6 gene inhibits proliferation and induces apoptosis in E6‑transformed keratinocytes

(2020) Chunjing Li et al.   Experimental and Therapeutic Medicine

A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy

(2020) Jinliang Gao et al.   Molecular Therapy-Oncolytics

LncRNA GACAT3 promotes gastric cancer progression by negatively regulating miR-497 expression

(2018) Li Feng et al.   BIOMEDICINE & PHARMACOTHERAPY

Novel long noncoding RNA GACAT3 promotes colorectal cancer cell proliferation, invasion, and migration through miR-149

(2018) Weiwei Zhou et al.   OncoTargets and Therapy

Origins of Bladder Cancer

(2016) Bogdan Czerniak et al.   Annual Review of Pathology-Mechanisms of Disease

Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis

(2016) Xue Wang et al.   JOURNAL OF HEPATOLOGY

Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer

(2016) Seonhyang Jeong et al.   MEDICINE

Directing cellular information flow via CRISPR signal conductors

(2016) Yuchen Liu et al.   NATURE METHODS

Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer

(2016) Youyou Zhang et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Novel long non-coding RNA GACAT3 promotes gastric cancer cell proliferation through the IL-6/STAT3 signaling pathway

(2016) Wanjing Shen et al.   TUMOR BIOLOGY

Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer

(2016) Youyou Zhang et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells

(2016) Jianfa Li et al.   Oncotarget

Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer

(2016) Yonghao Zhan et al.   Oncotarget

Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer

(2015) Jing Zhao et al.   CELL CYCLE

From Discovery to Function: The Expanding Roles of Long NonCoding RNAs in Physiology and Disease

(2015) Miao Sun et al.   ENDOCRINE REVIEWS

The emerging role of lncRNAs in cancer

(2015) Maite Huarte   NATURE MEDICINE

Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis

(2015) Xiaoling Tian et al.   BMJ Open

A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in Cancer

(2014) Xiaowen Hu et al.   CANCER CELL

Pin1 Regulates Osteoclast Fusion Through Suppression of the Master Regulator of Cell Fusion DC-STAMP

(2014) Rabia Islam et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer

(2014) Jun Zhao et al.   International Braz J Urol

Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells

(2014) Yuchen Liu et al.   Nature Communications

Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences

(2011) Doron Amit et al.   Journal of Translational Medicine